| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/18/2003 | EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/18/2003 | EP1319070A2 Mammalian receptor genes and uses |
| 06/18/2003 | EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/18/2003 | EP1319067A2 Human coagulation factor vii variants |
| 06/18/2003 | EP1319065A1 Nucleotide sequences which code for the ndka gene |
| 06/18/2003 | EP1319063A1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 06/18/2003 | EP1319024A2 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
| 06/18/2003 | EP1319023A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 06/18/2003 | EP1319022A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 06/18/2003 | EP1319021A2 Atp-binding cassette protein |
| 06/18/2003 | EP1319020A2 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Paritaria judaica |
| 06/18/2003 | EP1319019A1 Nucleotide sequences which code for the dps gene of c. glutamicum |
| 06/18/2003 | EP1319018A2 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nucleic acid |
| 06/18/2003 | EP1319017A2 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
| 06/18/2003 | EP1319016A1 Modified factor viii |
| 06/18/2003 | EP1319015A2 Olfactory and pheromones g-protein coupled receptors |
| 06/18/2003 | EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i |
| 06/18/2003 | EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 06/18/2003 | EP1318828A1 Orally administered peptides to ameliorate atherosclerosis |
| 06/18/2003 | EP1318827A1 Polymer-modified synthetic proteins |
| 06/18/2003 | EP1232247A4 Modulation of signal transduction |
| 06/18/2003 | EP1212095B1 Process to make a sustained release formulation |
| 06/18/2003 | EP1181306A4 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 06/18/2003 | EP1157125A4 Monkey gonadotropin releasing hormone receptor |
| 06/18/2003 | EP1151005B1 Peptide variants of the tumour marker muc1 and the use thereof |
| 06/18/2003 | EP1109823A4 Modifications of the vegf receptor-2 protein and methods of use |
| 06/18/2003 | EP1032428B1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 06/18/2003 | EP0960338B1 Diagnostic methods and compositions based on the distribution of rad51 |
| 06/18/2003 | EP0891427B1 Expression of hgv antigens and their use |
| 06/18/2003 | EP0757993B1 Preventive for circulatory diseases |
| 06/18/2003 | EP0638124B1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 06/18/2003 | EP0538404B1 Fibroblast growth factor receptors |
| 06/18/2003 | CN1425136A Assay of isomerised and/or optically inverted proteins and protein fragments |
| 06/18/2003 | CN1425135A Cytokine-like peptide |
| 06/18/2003 | CN1425072A Gene therapy of HIV-positive patients by the expression of membrane-anchored gp41 peptides |
| 06/18/2003 | CN1425070A Rice-origin gibberellin 2 & š�-hydroxylase genes and utilization thereof |
| 06/18/2003 | CN1425069A Method for purifying proteins |
| 06/18/2003 | CN1425068A Fungal transcriptional activator useful in methods for producing polypeptides |
| 06/18/2003 | CN1425066A Novel stra6 polypeptides |
| 06/18/2003 | CN1425065A Method of controlling telomere length |
| 06/18/2003 | CN1425027A HCV non-structural polypeptide |
| 06/18/2003 | CN1425024A Haemostatically active preparation containing VWF and production thereof |
| 06/18/2003 | CN1425023A Transgenic mice containing TRP gene disruptions |
| 06/18/2003 | CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/18/2003 | CN1424404A Human tumour concerned genes in sub-zone 3 of zone 3 of region 1 of chromosome 17 and inspecting reagent box |
| 06/18/2003 | CN1424399A Salmon calcitonin analogues and expression method for the same in vegetable oils |
| 06/18/2003 | CN1424325A Production of reorganized human parathyroid hormone 1-34 peptide |
| 06/18/2003 | CN1424324A Cell death regulating protein concerned with heart failure |
| 06/18/2003 | CN1424323A Preparation and use of secondary crystallized super purified radix trichosanthis protein |
| 06/18/2003 | CN1111540C Tandem synthetic HIV-1 peptides |
| 06/18/2003 | CN1111429C Urease-based vaccine against HeIicobacter infection |
| 06/17/2003 | US6580017 Into a recipient mammal when it is in the 2 to 8 cell stage of embryogenesis; use to produce a cloned or transgenic mammal |
| 06/17/2003 | US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/17/2003 | US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist |
| 06/17/2003 | US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 06/17/2003 | US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase |
| 06/17/2003 | US6579968 Cyclic peptide of given amino acid sequence; stimulates male erection; less side effects; melanocortin receptor-specific pharmaceutical composition |
| 06/17/2003 | US6579967 Cyclic peptide of given amino acid sequence; improves binding strength by adding a carbamoyl moiety at N-terminus; useful in determining tissue/cellular expression and in drug screening |
| 06/17/2003 | US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies |
| 06/17/2003 | US6579854 Diagnosis and management of infection caused by chlamydia |
| 06/17/2003 | US6579852 OBG3 globular head and uses thereof for decreasing body mass |
| 06/17/2003 | US6579850 Polypeptide, novel DNA and novel antibody |
| 06/17/2003 | US6579849 Antibiotic peptides from bovine milk |
| 06/17/2003 | US6579848 Treating hyperpigmentation with melanin production inhitors peptide |
| 06/17/2003 | US6579723 Method of recovering highly purified vWF or factor VIII/vWF-complex |
| 06/17/2003 | US6579716 Better emergence characteristics and improved seedling growth under low-light environments |
| 06/17/2003 | US6579715 Isolated nucleic acid molecule of given nucleotide sequence; can use in diagnosis and treatment of diseases |
| 06/17/2003 | US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/17/2003 | US6579703 Enhanced protein thermostability and temperature resistance |
| 06/17/2003 | US6579702 Mammalian tolloid-like gene and protein |
| 06/17/2003 | US6579701 Drosophila homologues of genes and proteins implicated in cancer and methods of use |
| 06/17/2003 | US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems |
| 06/17/2003 | US6579698 Of subtilisn from Streptomyces of given sequence comprising substitution mutation; used in detergents and cleaning products |
| 06/17/2003 | US6579697 Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/17/2003 | US6579696 Comprising diaminobutyric acid having a gamma amino group and amino acid selected from cysteine, alanine and lysine; use in prevention and treatment of sepsis |
| 06/17/2003 | US6579692 Method of screening apoptosis inducing substances |
| 06/17/2003 | US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor |
| 06/17/2003 | US6579689 Modulation of γ-secretase activity |
| 06/17/2003 | US6579684 Assay of YKL-40 as a marker for cancer |
| 06/17/2003 | US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins |
| 06/17/2003 | US6579679 Detecting the expression of a presenilin-2 splicing variant lacking exon 5 using nucleic acids or polypeptides; use in diagnosis and treatment of Alzheimer's disease |
| 06/17/2003 | US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result |
| 06/17/2003 | US6579677 Compositions and methods for plant pathogen resistance |
| 06/17/2003 | US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs |
| 06/17/2003 | US6579674 Administering antisense VA 1 (ava 1) oligodeoxynucleotides with carrier |
| 06/17/2003 | US6579537 Fibrinogen and fibronectin-containing solution is treated with a precipitating formulation which comprises components that modify solubility of fibrinogen and/or fibronectin, so that in a single-step precipitation, precipitate is formed |
| 06/17/2003 | US6579528 Vaccines; genetically engineering |
| 06/17/2003 | US6579527 Recombinant Pallas's cat FIV (FIV-Oma) virus, FIV-Oma3; vectors; antigens have broad specificity for immunization of cats; also use in diagnosis |
| 06/17/2003 | US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 06/17/2003 | US6579524 Polypeptide having amino acid sequence of C-terminal part of circumsporozoite protein of Plasmodium; oxidized cysteine residue pairs |
| 06/17/2003 | CA2232410C Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 06/17/2003 | CA2222128C Surface anchoring vector and system for foreign proteins thereof |
| 06/17/2003 | CA2129820C Dna sequences encoding novel growth/differentiation factors |
| 06/17/2003 | CA2123315C Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
| 06/17/2003 | CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 06/17/2003 | CA2046654C Radiolabeled proteins for diagnostic or therapeutic use |
| 06/12/2003 | WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 06/12/2003 | WO2003048767A2 Use of elavl-1 gene in the detection and modulation of apoptosis |
| 06/12/2003 | WO2003048394A1 Polynucleotides and polypeptides associated with the development of osteoarthritis |
| 06/12/2003 | WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine |